VX1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vertex Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 393.65 EUR -0.94%

Market Cap: €46.9B

V	Vertex Pharmaceuticals Inc DUS:VX1	US
N	Niterra Co Ltd XMUN:NGK	JP
S	Siemens AG SIX:SIN	DE
A	Adecco Group AG XBER:ADI1	CH
D	Deutsche Telekom AG XMUN:DTE	DE
	Monster Beverage Corp NASDAQ:MNST	US
T	TAG Immobilien AG DUS:TEG	DE
N	News Corp F:NC0B	US
W	West Pharmaceutical Services Inc SWB:WPS	US
A	Alphabet Inc BMV:GOOGL	US
K	Kumba Iron Ore Ltd XBER:KUI	ZA
	Baloise Holding AG SIX:BALN	CH
A	ASML Holding NV MIL:ASML	NL
	Ezenia! Inc OTC:EZEN	US

Profitability Summary

Vertex Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

87%

Declining Gross Margin

88% > 86%

Exceptional Operating Margin

39%

Strong 3Y Average Operating Margin

41%

Declining Operating Margin

49% > 39%

Exceptional Net Margin

36%

Sustainable 3Y Average Net Margin

21%

Net Margin is Increasing

35% > 36%

Exceptional Free Cash Flow Margin

26%

Strong 3Y Average Free Cash Flow Margin

18%

Declining Free Cash Flow Margin

42% > 26%

Positive ROE

24%

Positive 3Y Average ROE

Positive 3Y Average ROIC

11%

Declining ROIC

50% > 25%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.